Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic

Affiliations

¹ Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
² Department of Medicine, University of California, Los Angeles, CA, USA.
³ Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
⁴ Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
⁵ Department of Medicine, University of Washington, Seattle, WA, USA.
⁶ Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, USA.
⁷ Department of Emergency Medicine, Yale University, New Haven, CT, USA.
⁸ Department of Energy Medicine, Virginia Commonwealth, Richmond, VA, USA.
⁹ Altman Clinical and Translational Research Institute, University of California, San Diego, CA, USA.

Editorial

Minn A Oh et al. J Clin Transl Sci. 2024.

. 2024 Oct 15;8(1):e153.

doi: 10.1017/cts.2024.607. eCollection 2024.

¹ Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
² Department of Medicine, University of California, Los Angeles, CA, USA.
³ Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
⁴ Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
⁵ Department of Medicine, University of Washington, Seattle, WA, USA.
⁶ Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, USA.
⁷ Department of Emergency Medicine, Yale University, New Haven, CT, USA.
⁸ Department of Energy Medicine, Virginia Commonwealth, Richmond, VA, USA.
⁹ Altman Clinical and Translational Research Institute, University of California, San Diego, CA, USA.

No abstract available

Conflict of interest statement

None.

1. National Institutes of Health. “COVID-19 Therapeutics prioritized for testing in clinical trials,”. Accessed at https://www.nih.gov/research-training/medical-research-initiatives/activ... June 18, 2024. Accessed October 5, 2023.
1. National Institute of Health. “Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV).”. Accessed at https://www.nih.gov/research-training/medical-research-initiatives/activ... on June18218, 2024. Accessed May 21, 2024.
1. American College of Surgeons. “COVID-19: Executive Orders by State on Dental, Medical, and Surgical Procedures,”. Accessed at https://www.facs.org/for-medical-professionals/covid-19/legislative-regu... on JuneJune 18, 2024. Accessed May 4, 2020.
1. Bureau⁴ of Transportation Statistics. “COVID-19 Related Transportation Statistics,”. Accessed at https://www.bts.gov/covid-19 on June 18, 2024. Accessed April 18, 2023.
1. Kim K. Impacts of COVID-19 on transportation: summary and synthesis of interdisciplinary research. Transp Res Interdisc Res. 2021;9:100305. doi: 10.1016/j.trip.2021.100305. - DOI - PMC - PubMed